Awani Review

Complete News World

30 million vaccines unused: Why Astrogenica has not yet been vaccinated in the United States – Politics

Although the estrogen vaccine is used in more than 70 countries around the world, it is not yet approved in the United States. Was According to the New York Times, Former President Donald Trump AstraZeneca pledged $ 1.2 billion last May to develop and produce the vaccine. In addition, the manufacturer must supply 300 million cans to the United States.

The newspaper writes that 30 million vaccine doses have already been filled at a single facility in the state of Ohio, and several million more drugs have been produced in a laboratory in Maryland. But why is AstraZeneca not yet vaccinated in the United States? Why are millions of cans lying unused?

[Wenn Sie alle aktuellen Nachrichten live auf Ihr Handy haben wollen, empfehlen wir Ihnen unsere runderneuerte App, die Sie hier fürApple- und Android-Geräte herunterladen können.]

The background to this is that the results of medical studies in the United States are not yet available, according to a New York Times report. The British-Swedish company has not yet applied to the US FDA for emergency approval.

In the fall, work on the study was halted for nearly seven weeks. AstraZeneca was slow to provide evidence to the FDA that the vaccine did not cause severe neurological side effects in both study participants.

The widespread use of this vaccine in the United States has sparked a debate in Washington about whether or not it should be given to other countries that need it most urgently.

“Other governments have reportedly returned to the US government regarding donations of AstraZeneca cans. We have asked the US government to carefully examine these requests,” a company spokesman was quoted as saying.

See also  The UK is once again raising its ambitions to reduce greenhouse gas emissions

Some US health officials have recommended sending the vaccine to Brazil, the United Kingdom or the European Union. EU Council President Charles Michael recently criticized the United States and Great Britain for “imposing a genuine ban on the export of vaccines or vaccine components”.

U.S. Government Spokeswoman Jen Psaki confirmed that there have been requests from many countries for vaccine levels, but the US government has not yet provided them to any other states. “So this is not about Europe.” Biden’s first task is to tackle the ongoing crisis in the United States, which is still killing 1,400 people a day. On Thursday, Sackie said: “There is no export ban.”

Biden said Wednesday: “If we have a surplus, we will share it with the rest of the world.” But he added: “We want to make sure Americans are taken care of first.”

Astrogeneka which has no advantage over Johnson & Johnson

However, it should not take long for AstraZeneca to be approved in the United States because vaccine doses (like other manufacturers) only have a certain shelf life. According to the New York Times, it can only be stored in the refrigerator at room temperature for six months.

Meanwhile, the Biden government is trying to order additional items of already approved vaccines. These are Johnson & Johnson, Biotech / Pfizer and Moderna.

Astrogeneka will eventually be no longer needed or only needed for a short time. This has to do with the fact that there is no greater benefit to AstraZeneca than the Johnson & Johnson vaccine. Johnson & Johnson uses a similar technique, but only one dose of vaccine is required.

See also  United Kingdom: Who will pay for Prince Andrew's embarrassing $ 12 million deal?

US President Joe Biden has announced that the vaccine will be dramatically eliminated, and that all adults in the United States will be vaccinated by May 1. In his first big television speech on Thursday evening, he promised that Americans would be able to come together again in small groups to celebrate Independence Day on July 4th.

In the United States, with a population of about 330 million, the vaccine campaign is advancing rapidly. According to the CDC Health Authority, one in four adults has now received at least one dose of the vaccine. (with dpa)